Literature DB >> 28741974

Sarcopenia and physical function are associated with inflammation and arteriosclerosis in community-dwelling people: The Yakumo study.

Tetsuro Hida1, Shiro Imagama1, Kei Ando1, Kazuyoshi Kobayashi1, Akio Muramoto1, Kenyu Ito1, Yoshimoto Ishikawa1, Mikito Tsushima1, Yoshihiro Nishida1, Naoki Ishiguro1, Yukiharu Hasegawa2.   

Abstract

OBJECTIVES: Sarcopenia reduces physical function, while chronic inflammation causes arteriosclerosis and decreases skeletal muscle. We conducted a cross-sectional study to elucidate the associations among sarcopenia, physical function, arteriosclerosis, and inflammation in community-dwelling people.
METHODS: We recruited 335 participants in an annual health checkup. We diagnosed sarcopenia based on appendicular skeletal muscle mass index (aSMI) assessed by bioelectrical impedance analysis. We measured several physical function tests, blood pressure, and serum levels of high-sensitivity C-reactive protein (hs-CRP), total cholesterol, and low-density lipoprotein cholesterol.
RESULTS: After controlling for age, sex, and BMI, participants in the sarcopenia group showed lower performance in all measured physical tests than the normal group. Arteriosclerosis risk factors, including blood pressure, cholesterol levels, and hs-CRP, were significantly higher in the sarcopenia group than in the normal group. hs-CRP and total cholesterol levels were significant risk factors of sarcopenia. The aSMI, grip strength, and maximum stride length were negatively related to hs-CRP level.
CONCLUSIONS: Community-dwelling people with sarcopenia had higher levels of hs-CRP and a higher risk for arteriosclerosis. The serum level of hs-CRP was an independent risk factor for sarcopenia and was associated with physical function. These findings indicate that chronic inflammation may relate arteriosclerosis and sarcopenia simultaneously.

Entities:  

Keywords:  Atherosclerosis; C-reactive protein; bioelectrical impedance analysis; intima–media complex thickness; sarcopenia

Mesh:

Year:  2017        PMID: 28741974     DOI: 10.1080/14397595.2017.1349058

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  16 in total

1.  Systemic Inflammation in the Recovery Stage of Stroke: Its Association with Sarcopenia and Poor Functional Rehabilitation Outcomes.

Authors:  Yoshihiro Yoshimura; Takahiro Bise; Fumihiko Nagano; Sayuri Shimazu; Ai Shiraishi; Makio Yamaga; Hiroaki Koga
Journal:  Prog Rehabil Med       Date:  2018-05-18

2.  Neutrophil-lymphocyte Ratio and C-Reactive Protein Levels are not Associated with Strength, Muscle Mass, and Functional Capacity in Kidney Transplant Patients.

Authors:  Heitor O Santos; Larissa S Limirio; Aline S Dos Reis; Rafaela Nehme; João Pedro Floriano; Gederson K Gomes; Gustavo D Pimentel; Erick P de Oliveira
Journal:  Inflammation       Date:  2022-06-21       Impact factor: 4.092

Review 3.  Sarcopenia versus cancer cachexia: the muscle wasting continuum in healthy and diseased aging.

Authors:  Alexandra Moreira-Pais; Rita Ferreira; Paula A Oliveira; José A Duarte
Journal:  Biogerontology       Date:  2021-07-29       Impact factor: 4.277

Review 4.  Physical Exercise and Myokines: Relationships with Sarcopenia and Cardiovascular Complications.

Authors:  Sandra Maria Barbalho; Uri Adrian Prync Flato; Ricardo José Tofano; Ricardo de Alvares Goulart; Elen Landgraf Guiguer; Cláudia Rucco P Detregiachi; Daniela Vieira Buchaim; Adriano Cressoni Araújo; Rogério Leone Buchaim; Fábio Tadeu Rodrigues Reina; Piero Biteli; Daniela O B Rodrigues Reina; Marcelo Dib Bechara
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

5.  Presarcopenia Is an Independent Risk Factor for Carotid Atherosclerosis in Chinese Population with Metabolic Syndrome.

Authors:  Yuan Cao; Ming Zhong; Yuke Zhang; Zijie Zheng; Yapeng Liu; Xiaoning Ni; Lu Han; Ming Song; Wei Zhang; Zhihao Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2020-01-09       Impact factor: 3.168

6.  Bioelectrical Impedance Analysis and Manual Measurements of Neck Circumference Are Interchangeable, and Declining Neck Circumference Is Related to Presarcopenia.

Authors:  Masaaki Machino; Kei Ando; Kazuyoshi Kobayashi; Hiroaki Nakashima; Satoshi Tanaka; Shunsuke Kanbara; Sadayuki Ito; Taro Inoue; Hiroyuki Koshimizu; Taisuke Seki; Shinya Ishizuka; Yasuhiko Takegami; Yukiharu Hasegawa; Shiro Imagama
Journal:  Biomed Res Int       Date:  2021-03-29       Impact factor: 3.411

7.  The dual presence of frailty and locomotive syndrome is associated with a greater decrease in the EQ-5D-5L index.

Authors:  Satoshi Tanaka; Kei Ando; Kazuyoshi Kobayashi; Hiroaki Nakashima; Taisuke Seki; Shinya Ishizuka; Masaaki Machino; Masayoshi Morozumi; Shunsuke Kanbara; Sadayuki Ito; Tokumi Kanemura; Naoki Ishiguro; Yukiharu Hasegawa; Shiro Imagama
Journal:  Nagoya J Med Sci       Date:  2021-02       Impact factor: 1.131

8.  Effect of dietary omega-3 fatty acid supplementation on frailty-related phenotypes in older adults: a systematic review and meta-analysis protocol.

Authors:  Joanne Stocks; Ana M Valdes
Journal:  BMJ Open       Date:  2018-05-17       Impact factor: 2.692

9.  Waist Circumference Measured by Bioelectrical Impedance Analysis Is Interchangeable with Manual Measurement: Increased Waist Circumference Is Associated with Locomotive Syndrome Risk.

Authors:  Satoshi Tanaka; Kei Ando; Kazuyoshi Kobayashi; Taisuke Seki; Shinya Ishizuka; Masaaki Machino; Masayoshi Morozumi; Shunsuke Kanbara; Sadayuki Ito; Taro Inoue; Naoki Ishiguro; Yukiharu Hasegawa; Shiro Imagama
Journal:  Biomed Res Int       Date:  2019-09-25       Impact factor: 3.411

10.  Musculoskeletal Factors and Geriatric Syndromes Related to the Absence of Musculoskeletal Degenerative Disease in Elderly People Aged over 70 Years.

Authors:  Shiro Imagama; Kei Ando; Kazuyoshi Kobayashi; Taisuke Seki; Shinya Ishizuka; Masaaki Machino; Satoshi Tanaka; Masayoshi Morozumi; Shunsuke Kanbara; Sadayuki Ito; Taro Inoue; Hiroaki Nakashima; Naoki Ishiguro; Yukiharu Hasegawa
Journal:  Biomed Res Int       Date:  2019-11-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.